Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer

Abstract

The role of serum CYFRA 21-1 level in patients with non-small cell lung cancer (NSCLC) remains to be defined. To re-evaluate the impact of serum CYFRA 21-1 in NSCLC survival, we performed this meta-analysis. Databases were searched to identify relevant studies reported after the publication of a meta-analysis in 2004. Totally, 31 studies with 6394 patients… (More)
DOI: 10.1038/srep09444

Topics

Cite this paper

@inproceedings{Xu2015PrognosticVO, title={Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer}, author={Youtao Xu and Lei Xu and Mantang Qiu and Jie Wang and Qing Zhou and Lin Xu and Jian Wang and Rong Yin}, booktitle={Scientific reports}, year={2015} }